Relief Therapeutics Holding AG (RLF.SW)

CHF 2.41

(2.55%)

Total Debt Summary of Relief Therapeutics Holding AG

Relief Therapeutics Holding AG's latest annual total debt in 2023 was 4.31 Million CHF , down -0.76% from previous year.
Relief Therapeutics Holding AG's latest quarterly total debt in 2024 Q2 was 2.41 Million CHF , down 0.0% from previous quarter.
Relief Therapeutics Holding AG reported annual total debt of 4.34 Million CHF in 2022, up 1.88% from previous year.
Relief Therapeutics Holding AG reported annual total debt of 4.26 Million CHF in 2021, up 378.56% from previous year.
Relief Therapeutics Holding AG reported quarterly total debt of 4.31 Million CHF for 2023 Q4, down 0.0% from previous quarter.
Relief Therapeutics Holding AG reported quarterly total debt of 4.31 Million CHF for 2023 FY, down -0.76% from previous quarter.

Annual Total Debt Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Total Debt of Relief Therapeutics Holding AG (2023 - 2007)

Year	Total Debt	Total Debt Growth
2023	4.31 Million CHF	-0.76%
2022	4.34 Million CHF	1.88%
2021	4.26 Million CHF	378.56%
2020	891 Thousand CHF	-48.76%
2019	1.73 Million CHF	65.15%
2018	1.05 Million CHF	4.05%
2017	1.01 Million CHF	15.26%
2016	878 Thousand CHF	-80.93%
2015	4.6 Million CHF	18.05%
2014	3.9 Million CHF	-53.86%
2013	8.45 Million CHF	208.3%
2012	2.74 Million CHF	305.02%
2011	676.98 Thousand CHF	72.03%
2010	393.52 Thousand CHF	18.8%
2009	331.24 Thousand CHF	-35.8%
2008	515.94 Thousand CHF	-86.33%
2007	3.77 Million CHF	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	2.41 Million CHF	0.0%
2023 Q4	4.31 Million CHF	0.0%
2023 FY	4.31 Million CHF	-0.76%
2023 Q2	4.55 Million CHF	0.0%
2022 FY	4.34 Million CHF	1.88%
2022 Q4	4.34 Million CHF	0.0%
2022 Q2	2.82 Million CHF	0.0%
2021 FY	4.26 Million CHF	378.56%
2021 Q2	7.99 Million CHF	0.0%
2021 Q4	4.26 Million CHF	0.0%
2020 FY	891 Thousand CHF	-48.76%
2020 Q4	891 Thousand CHF	0.0%
2020 Q2	3.4 Million CHF	0.0%
2019 Q2	1.37 Million CHF	0.0%
2019 FY	1.73 Million CHF	65.15%
2019 Q4	1.73 Million CHF	0.0%
2018 Q4	4.64 Million CHF	0.0%
2018 Q2	5.39 Million CHF	0.0%
2018 FY	1.05 Million CHF	4.05%
2017 FY	1.01 Million CHF	15.26%
2017 Q4	1.01 Million CHF	0.0%
2017 Q2	876 Thousand CHF	0.0%
2016 Q4	878 Thousand CHF	0.0%
2016 Q2	3.39 Million CHF	0.0%
2016 FY	878 Thousand CHF	-80.93%
2015 Q4	4.6 Million CHF	0.0%
2015 Q2	3.03 Million CHF	0.0%
2015 FY	4.6 Million CHF	18.05%
2014 Q2	8.97 Million CHF	0.0%
2014 FY	3.9 Million CHF	-53.86%
2014 Q4	3.9 Million CHF	0.0%
2013 FY	8.45 Million CHF	208.3%
2013 Q4	8.45 Million CHF	0.0%
2013 Q2	2.62 Million CHF	0.0%
2012 Q4	2.74 Million CHF	0.0%
2012 FY	2.74 Million CHF	305.02%
2012 Q2	2.11 Million CHF	0.0%
2011 Q2	399.86 Thousand CHF	0.0%
2011 Q4	676.98 Thousand CHF	0.0%
2011 FY	676.98 Thousand CHF	72.03%
2010 Q2	238.67 Thousand CHF	0.0%
2010 FY	393.52 Thousand CHF	18.8%
2010 Q4	393.52 Thousand CHF	0.0%
2009 Q4	331.24 Thousand CHF	0.0%
2009 FY	331.24 Thousand CHF	-35.8%
2009 Q2	460.31 Thousand CHF	0.0%
2008 FY	515.94 Thousand CHF	-86.33%
2008 Q4	515.94 Thousand CHF	0.0%
2007 FY	3.77 Million CHF	0.0%

Peer Total Debt Comparison of Relief Therapeutics Holding AG

Name	Total Debt	Total Debt Difference
Addex Therapeutics Ltd	344.33 Thousand CHF	-1151.975%
BB Biotech AG	304.9 Million CHF	98.586%
Basilea Pharmaceutica AG	128.6 Million CHF	96.648%
Evolva Holding SA	- CHF	-Infinity%
Idorsia Ltd	1.2 Billion CHF	99.642%
Kuros Biosciences AG	5.51 Million CHF	21.874%
Molecular Partners AG	3.65 Million CHF	-18.045%
Santhera Pharmaceuticals Holding AG	25.06 Million CHF	82.799%